Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $8.43 Million - $9.78 Million
-75,800 Reduced 17.68%
352,900 $40.1 Million
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $16.1 Million - $17.3 Million
-130,100 Reduced 23.28%
428,700 $53.1 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $14.2 Million - $16.6 Million
125,600 Added 28.99%
558,800 $73.7 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $28.5 Million - $31 Million
284,100 Added 190.54%
433,200 $47.2 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $6.03 Million - $6.7 Million
-58,600 Reduced 28.21%
149,100 $15.3 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $7.14 Million - $7.78 Million
65,700 Added 46.27%
207,700 $24 Million
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $8.86 Million - $9.89 Million
86,100 Added 154.03%
142,000 $15.1 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $2.4 Million - $3.08 Million
-27,500 Reduced 32.97%
55,900 $6.2 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $7.05 Million - $7.92 Million
83,400 New
83,400 $7.18 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $887,040 - $1.23 Million
-14,000 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $8.67 Million - $9.78 Million
-111,700 Reduced 88.86%
14,000 $1.27 Million
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $4.91 Million - $5.36 Million
64,600 Added 105.73%
125,700 $10.6 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $1.6 Million - $1.87 Million
22,900 Added 59.95%
61,100 $5.12 Million
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $2.18 Million - $2.49 Million
31,400 Added 461.76%
38,200 $3.18 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $392,292 - $461,312
6,800 New
6,800 $482,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.